Tumor markers in patients with relapse of colorectal carcinoma

Anticancer Research

Volumn 27, Issue 4 A, 2007, Pages 1901-1905

  Lipská, Ludmila ^a,b   Visokai, Vladimir ^a   Levý, Miroslav ^a   Svobodová, Šárka ^a   Kormunda, Stanislav ^a   Fínek, Jindřich ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b Thomayer Teaching Hospital   (Czech Republic)

Author keywords

Colorectal cancer; Follow up; Relapse; Tumor markers

Indexed keywords

CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; TUMOR MARKER;

CANCER EPIDEMIOLOGY; CANCER RELAPSE; CANCER RISK; CANCER STAGING; CANCER SURGERY; COLORECTAL CARCINOMA; CONFERENCE PAPER; CONTROLLED STUDY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL;

CA-19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; FOLLOW-UP STUDIES; HUMANS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 34250785000     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (16)

1. Ishizuka D, Shirai Y, Sakai Y and Hatakeyama K: Colorectal carcinoma liver metastases: clinical significance of preoperative measurement of serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels. Int J Colorectal Dis 16: 32-37, 2001.
2. Holubec L Jr, Topolcan O, Pikner R, Pecen L, Holubec Sen L, Finek J, Ludvikova M and Cerna M: Criteria for the selection of referential groups in tumor marker statistical evaluation on the basis of a retrospective study. Anticancer Res 23(2A): 865-870, 2003.
3. Chapman MA, Buckley D, Henson DB and Armitage NC: Preoperative carcinoembryonic antigen is related to tumour stage and long-term survival in colorectal cancer. Br J Cancer 78: 1346-1349, 1998.
4. Yu BM: Evaluation of combined CA-19-9 and CEA assay in monitoring recurrences and metastases of colorectal cancer, Zhonghua Wai Ke Za Zhi 30(12): 707-709, 1992.
5. Holubec L Jr, Topolcan O, Pikner R, Pecen L, Vaclavickova J, Wirthova M,Molacek J, Stieber P, Holdenrieder S and Finek J: The significance of CEA, CA19-9 and CA72-4 in the detection of colorectal carcinoma recurrence. Anticancer Res 20(6D): 5237-5244, 2000.
6. International Statistical Classification of Diseases and Related Health Problems. 10th Revision. Geneva: World Health Organisation, 1993.
7. UICC: TNM Classification of Malignant Tumours. 6th Edition. New Jersey, UICC, 2002.
8. Tumour markers in gastrointestinal cancers - EGTM recommendations. http://egtm.web.med.uni-muenchen.de/detail/3.htm
9. Jeffery GM, Hickey BE and Hider P: Follow-up strategies for patients treated for non-metastatic colorectal cancer. Cochrane Database Syst Rev. http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD002200/frame. html
10. Wille-Jorgensen PA and Madsen MR: Follow-up of patients after curative surgery for colorectal cancer. Ugeskr Laeger 167(44): 4189-4191, 2005.
11. Figueredo A, Rumble RB, Maroun J, Earle CC, Cummings B, McLeod R, Zuraw L and Zwaal C: Follow-up of patients with curatively resected colorectal cancer: a practice guideline, BMC Cancer 6(3): 26, 2003.
12. Liska V, Treska V, Holubec L, Skalicky T, Sunar A, Topolcan O and Finek J. Prognostic factors of early recurrence of colorectal liver metastases and their usage in clinical praxis. Rozhl Chir 85(4): 163-168, 2006.
13. Makela JT, Laitinen SO and Kairaluoma MI: Five-year follow-up after radical surgery for colorectal cancer. Results of a prospective randomized trial. Arch Surg 130: 1062-1067, 1995.
14. Ohlsson B, Breland U, Ekberg H, Graffner H and Trannberg KG: Follow-up after curative surgery for colorectal carcinoma. Randomized comparison with no follow-up. Dis Colon Rectum 38: 619-626, 1995.
15. Pietra N, Sarli L, Costi R, Ouchemi C, Grattarola M and Peracchia A: Role of follow-up in management of local recurrences of colorectal cancer. Dis Colon Rectum 41: 1127-1133, 1998.
16. Secco GB, Fardelli R, Gianquinto D, Bonfante P, Baldi E, Ravera G, Derchi L and Ferraris R: Efficacy and cost of risk-adapted follow-up in patients after colorectal cancer surgery: a prospective, randomized and controlled trial. Eur J Surg Oncol 28: 418-423, 2002.